期刊
CIRCULATION
卷 137, 期 24, 页码 2551-2553出版社
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1161/CIRCULATIONAHA.118.035289
关键词
atherosclerosis; biomarkers; precision medicine; residual risk; secondary prevention
资金
- Abbott Diagnostics
- Amgen
- Novo Nordisc
- Regeneron
- Ortho Clinical Diagnostics
- Quidel Cardiovascular
- Roche Diagnostics